How Much Weight Should I Lose with Semaglutide?

Last reviewed: June 4, 2026

Last updated: June 4, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide injection has become one of the most effective weight loss medications available, but the amount of weight you should expect to lose depends on your unique biology, starting weight, and lifestyle factors. Clinical data shows that patients on semaglutide lose between 5% and 22% of their baseline body weight, with most people achieving meaningful results within the first three months of therapy. Understanding your individual weight loss potential helps you set realistic goals and stay motivated throughout treatment.

Average Semaglutide Weight Loss Results by Clinical Trial

Major clinical trials have documented semaglutide's effect on weight reduction across diverse patient populations. In the STEP 1 trial, patients receiving 2.4 mg weekly semaglutide lost an average of 15.3% of their baseline body weight compared to 2.6% in the placebo group over 68 weeks. The STEP 2 trial, which enrolled people with type 2 diabetes, showed average weight loss of 9.6% with semaglutide versus 3.4% with placebo. These results represent some of the most significant weight loss outcomes ever demonstrated in pharmaceutical trials.

Individual outcomes within these trials showed wide variation, with some patients losing as little as 5% of body weight while others achieved losses exceeding 20%. Factors contributing to this variation include baseline body weight, metabolism rate, genetics, adherence to dosing schedules, and dietary consistency. Your personal weight loss trajectory may differ substantially from average trial results, which is why PlexusDx offers genetic testing to understand your individual peptide-pathway response.

How Your Starting Weight Affects Weight Loss Expectations

Patients beginning semaglutide therapy with higher baseline body weight often experience larger absolute pound losses, though percentage weight loss tends to be similar across weight categories. Someone weighing 300 pounds losing 15% would lose 45 pounds, while someone at 200 pounds losing 15% would lose 30 pounds. This difference in absolute numbers is normal and reflects how percentages work across different starting points. Realistic goal-setting should focus on percentage-based targets rather than comparing your outcomes to someone else's absolute numbers.

Most patients notice meaningful weight reduction within 4 to 12 weeks of starting semaglutide, with the majority of total weight loss occurring during months one through six of therapy. After six months, the rate of weight loss typically slows, though continued gradual reduction often persists. The plateau effect is natural and reflects your body reaching a new metabolic equilibrium at a lower weight. Some patients experience slight weight regain if they discontinue semaglutide, which is why ongoing treatment is often necessary to maintain results.

Factors That Influence Individual Semaglutide Response Rates

Your genetic makeup plays a significant role in how effectively semaglutide will work for your weight loss goals. The Precision Peptide Genetic Test offered by PlexusDx examines key variants including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313, which influence your appetite regulation and metabolic response to GLP-1 therapy. Understanding these genetic predispositions allows PlexusDx to map your individual peptide pathways and predict which compounds and doses may work best for your biology.

Beyond genetics, medication adherence, dietary choices, physical activity levels, sleep quality, and stress management all significantly impact weight loss outcomes. Patients who maintain consistent injection schedules and make modest dietary adjustments typically see better results than those who are inconsistent with dosing. PlexusDx's personalized approach takes these factors into account, allowing your healthcare provider to adjust your semaglutide dose based on your response rather than a one-size-fits-all protocol. Your dose may need to go up. Your price won't.

When to Expect Plateau and How to Overcome It

Weight loss plateaus typically occur around month four to six of semaglutide treatment, when your body has adapted to the medication's appetite-suppressing effects. This plateau doesn't mean the medication has stopped working—it means your appetite has genuinely decreased and your body has reached a lower set point. Continuing semaglutide during a plateau phase prevents weight regain, even if the scale isn't moving. Many patients mistake a plateau for treatment failure when it's actually a sign that the medication is successfully maintaining your new, lower weight.

Breaking through a plateau may require dose adjustments, dietary modifications, or increased physical activity rather than stopping the medication entirely. Some patients benefit from PlexusDx's tiered commitment options, which allow flexibility in adjusting their treatment approach without increasing their monthly cost. Others find that combining semaglutide with behavioral strategies—such as strength training, protein prioritization, or mindfulness practices—helps restart weight loss momentum. Consultation with your PlexusDx provider can help determine whether dose optimization or lifestyle changes would be most beneficial for your situation.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month of treatment) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $149/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

Is losing 15% of my body weight a realistic goal with semaglutide?

Clinical trial data supports 15% weight loss as an achievable average outcome, though individual results range from 5% to 22% of baseline body weight. PlexusDx's Precision Peptide Genetic Test helps identify whether your genetic profile suggests you may fall above or below this average.

How quickly will I lose weight after starting semaglutide injection?

Most patients notice appetite reduction within the first week and measurable weight loss within four weeks of starting semaglutide therapy. The most significant weight loss typically occurs during months one through six, after which the rate of loss gradually slows.

Can I achieve greater weight loss with higher semaglutide doses?

Higher doses generally produce slightly greater weight loss, but the relationship isn't linear—doubling your dose doesn't mean doubling your weight loss. PlexusDx offers compounded semaglutide injection starting at $149 per month, with dose adjustments available as your treatment progresses. Your dose may need to go up. Your price won't.

What happens to my weight if I stop taking semaglutide?

Research shows that patients who discontinue semaglutide often experience gradual weight regain over several months, though most don't return to their pre-treatment baseline. This pattern is why ongoing treatment is often recommended for sustained weight management.

How does genetic testing improve my semaglutide weight loss outcomes?

PlexusDx's Precision Peptide Genetic Test analyzes 14 peptide pathways and 150+ genetic insights to predict your individual response to GLP-1 compounds like semaglutide. Testing for variants in GLP1R, GIPR, FTO, and MC4R genes helps your provider optimize your specific dose and medication choice.

How Much Weight Should I Lose with Ozempic?